All In Biotech

Drug Trial Radar · NCT01184638

Long-term Outcome of General Anesthesia on Dysgnosia

Long-term Outcome Followed-up of the Cognitive Disorders After General Anesthesia

Last checked: Nov 19, 2026Latest source record: Jan 14, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 10,000 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

10,000

Planned (sponsor's estimate)

Start

Aug 2010

Primary completion

Aug 2020

Study completion Aug 2020

Sponsor

Lead sponsor
Nanjing Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 19, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 10 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Cognitive disorders in patients underwent general anesthesia are discussed for decades, but whether there were precise relationship between general anesthesia and dysgnosia is yet to be guaranteed. Although controversial data reported from experimental studies in animals, the investigators still proposed that general anesthetics could impair the normally organized system of the central nervous system, which finally displayed a dysfunction of cognition after general anesthesia in a short- or long-term period. Therefore, different types of general anesthetics such as inhalational anesthetics and intravenous anesthetics, the investigators hypothesized, had a long-term influence on patients' cognitive ability.

Conditions

  • Delirium,
  • Dementia,
  • Amnestic,
  • Cognitive Disorders

Interventions

  • SevofluraneDrug

    1-8% sevoflurane for maintaining the whole period of general anesthesia

  • PropofolDrug

    1-4 mg/kg/h of propofol during the whole period of general anesthesia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cognitive abilityTime frame: The 10th year since postoperation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nanjing Maternity and Child Health Care Hospital

    Nanjing, Jiangsu, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.